• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

4

CATEGORIES

  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

6
6
6
11

PUBLISHED

0
1
2
11

PRODUCT TYPE

9
2

Search "Helix BioPharma Corp.-Deals & Alliances Report" returned 11 results.

PRODUCT TITLE

Helix BioPharma Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Project Synopsis: Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by...

June 2013
FROM
Companion Diagnostics - Global Strategic Business Report Companion Diagnostics - Global Strategic Business Report - Product Thumbnail Image

Companion Diagnostics - Global Strategic Business Report

This report analyzes the worldwide markets for Companion Diagnostics in US$ Thousand The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World Annual estimates...

September 2011
FROM
Medicated Skin Care Products - Global Business Strategic Report Medicated Skin Care Products - Global Business Strategic Report - Product Thumbnail Image

Medicated Skin Care Products - Global Business Strategic Report

This report analyzes the worldwide markets for Medicated Skin Care Products in US$ Million The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin...

May 2012
FROM

Theratechnologies Inc. (TH) - Financial and Strategic SWOT Analysis Review

Theratechnologies Inc. (TH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

May 2014
FROM

Non-Small Cell Lung Cancer - Pipeline Review, H2 2011

Non-Small Cell Lung Cancer - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Non-Small Cell Lung Cancer - Pipeline Review, H2 2011', provides an overview of the Non-Small Cell Lung Cancer...

September 2011
FROM

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition

In eight best-selling editions, Shara Rosen has detailed the market for in vitro diagnostic (IVD) testing, throughout the world,  in one complete volume. The report, The Worldwide Market for In Vitro...

July 2012
FROM
Standard & Poor's Extends Recovery Ratings To Unsecured Speculative-Grade Corporate Issues Mar 08 Standard & Poor's Extends Recovery Ratings To Unsecured Speculative-Grade Corporate Issues Mar 08 - Product Thumbnail Image

Standard & Poor's Extends Recovery Ratings To Unsecured Speculative-Grade Corporate Issues Mar 08

Abstract Standard & Poor's today has assigned recovery ratings to more than 1,800 unsecured loan and bond issues sold by nearly 900 speculative-grade rated corporate issuers in the U.S., Canada, and...

March 2008
Predictive Diagnostics - Global Strategic Business Report Predictive Diagnostics - Global Strategic Business Report - Product Thumbnail Image

Predictive Diagnostics - Global Strategic Business Report

This report analyzes the worldwide markets for Predictive Diagnostics in US$ Million The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World Annual...

September 2013
FROM
Standard & Poor's Extends Recovery Ratings To Unsecured Speculative-Grade Corporate Issues Mar 08 Standard & Poor's Extends Recovery Ratings To Unsecured Speculative-Grade Corporate Issues Mar 08 - Product Thumbnail Image

Standard & Poor's Extends Recovery Ratings To Unsecured Speculative-Grade Corporate Issues Mar 08

Abstract Standard & Poor's today has assigned recovery ratings to more than 1,800 unsecured loan and bond issues sold by nearly 900 speculative-grade rated corporate issuers in the U.S., Canada, and...

March 2008

Molecular Diagnostics in Infectious Disease Testing 2014

This publications report describes the specific segment of the in vitro diagnostics market known as molecular diagnostics testing for infectious disease. In the current medical diagnostics market, molecular...

September 2014
FROM
Recovery: Results Of Revisions To Recovery Rating Scale And Issue Level Rating Framework Jun 07 Recovery: Results Of Revisions To Recovery Rating Scale And Issue Level Rating Framework Jun 07 - Product Thumbnail Image

Recovery: Results Of Revisions To Recovery Rating Scale And Issue Level Rating Framework Jun 07

Abstract Standard & Poor's Ratings Services has reviewed its portfolio of almost 2,300 issue level and recovery ratings on speculative-grade secured loans and bonds, in connection with the May 30 release...

June 2007
Loading Indicator

Our Clients

Our clients' logos